Christine Fox insider trades

Open-market stock purchases and sales by Christine Fox, EVP, U.S. Commercial at Teva Pharmaceutical Industries Ltd, from SEC Form 4 filings since Nov 20, 2023.

Recent trades

DateStockTradeValue
Apr 30, 2026TEVA Teva Pharmaceutical Industries LtdSold$751K
Mar 5, 2026TEVA Teva Pharmaceutical Industries LtdSold$251K
Mar 5, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdSold$295K
Nov 20, 2025TEVA Teva Pharmaceutical Industries LtdSold$700K
Nov 20, 2025TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Nov 14, 2025TEVA Teva Pharmaceutical Industries LtdSold$753K

Companies traded

  • TEVA Teva Pharmaceutical Industries Ltd: 8 sales, last Apr 30, 2026

Get free alerts when Christine Fox files a new trade →